| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.25▲ | 1.26▲ | 1.26▼ | 1.29▼ | 1.38▼ |
| MA10 | 1.25▲ | 1.25▲ | 1.24▲ | 1.35▼ | 1.41▼ |
| MA20 | 1.26▲ | 1.24▲ | 1.25▲ | 1.38▼ | 1.27▼ |
| MA50 | 1.24▲ | 1.29▼ | 1.33▼ | 1.40▼ | 1.57▼ |
| MA100 | 1.28▼ | 1.34▼ | 1.36▼ | 1.25▼ | 2.33▼ |
| MA200 | 1.34▼ | 1.38▼ | 1.38▼ | 1.37▼ | 3.90▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.007▲ | 0.008▲ | -0.020▼ | 0.031▲ |
| RSI | 52.943▲ | 51.505▲ | 45.453▼ | 41.320▼ | 45.526▼ |
| STOCH | 25.783 | 55.109 | 63.311 | 22.199 | 38.534 |
| WILL %R | -61.538 | -44.444 | -44.444 | -84.615▼ | -72.603 |
| CCI | 4.714 | 39.736 | 49.007 | -137.795▼ | -58.197 |
|
Tuesday, August 26, 2025 09:00 AM
NEWTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid ...
|
|
Thursday, August 21, 2025 05:00 PM
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report)’s stock price fell 3.5% during trading on Thursday . The company traded as low as $1.35 and last traded at $1.36. 74,438 shares traded ...
|
|
Monday, August 11, 2025 08:59 PM
Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Expect decision to advance an oligomer ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 1.27 | 1.30 | 1.23 | 1.25 | 153,396 |
| 16/09/25 | 1.28 | 1.295 | 1.21 | 1.23 | 120,282 |
| 15/09/25 | 1.32 | 1.3636 | 1.22 | 1.26 | 198,084 |
| 12/09/25 | 1.39 | 1.39 | 1.30 | 1.32 | 163,335 |
| 11/09/25 | 1.34 | 1.41 | 1.33 | 1.39 | 122,136 |
| 10/09/25 | 1.46 | 1.465 | 1.35 | 1.35 | 129,169 |
| 09/09/25 | 1.41 | 1.44 | 1.38 | 1.44 | 94,255 |
| 08/09/25 | 1.47 | 1.47 | 1.39 | 1.41 | 125,834 |
| 05/09/25 | 1.39 | 1.46 | 1.38 | 1.44 | 112,871 |
| 04/09/25 | 1.40 | 1.40 | 1.335 | 1.38 | 95,054 |
|
|
||||
|
|
||||
|
|